ORTIN GLOBAL LIMITED (ORTINGLOBE) — corporate announcements

All
Important
Financial Update
Fund Raise
Board Meeting
Dividend/Bonus
JV/Acquisition
Investor Meet
Insider Trade
Pledging
Others

Download our app

Get the best experience on mobile

Join 5K+ users on Alpha Tribe

ORTIN GLOBAL LIMITED

$ORTINGLOBE

Incorporated in 1986, Ortin Laboratories Ltd is engaged in the manufacturing and trading of Pharmaceuticals, Drugs and Intermediates.

Pharmaceuticals

14-08-2026 | 07:55 pm

Ortin Global's board has approved Q1 FY27 unaudited financial results. For the quarter ended June 30, 2026, the company reported Net Sales of 1.16 and a Net Loss after tax of -33.79. EPS came in at -0.42.

PDF

11-07-2026 | 04:23 pm

ORTIN GLOBAL LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

PDF

09-07-2026 | 05:43 pm

Ortin Global clarified an NSE query regarding segment details. The company stated segment reporting isn't applicable as it operates solely in Drugs and Medicines. This confirms no change to previously disclosed financial results or investor interpretation.

PDF

24-06-2026 | 05:46 pm

ORTIN GLOBAL LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

PDF

15-06-2026 | 09:54 am

S. Murali Krishna Murthy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

PDF

Download our app

ORTIN GLOBAL LIMITED

ORTIN GLOBAL LIMITED

Outcome of Board Meeting

ORTIN GLOBAL LIMITED

Certificate under SEBI (Depositories and Participants) Regulations, 2018

ORTIN GLOBAL LIMITED

Reply to Clarification- Financial results

ORTIN GLOBAL LIMITED

Trading Window

ORTIN GLOBAL LIMITED

Disclosure under SEBI Takeover Regulations